About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
DEBATE: Should MDS Diagnosis Still Be Mainly Based on Morphology? Yes
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Robert Paul Hasserjian
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Robert Paul Hasserjian
26 views
October 23, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:18
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations for Ibrutinib-Intolerant Patients - A Patie…
Feat.
M. Shadman
Featured Video
14:41
Sanofi
Efficacy and Safety of a Treatment Option for Adults with Multiple M…
Feat.
J. Mikhael
Session II: Myelodysplastic Syndromes
12:31
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Selecting the Right Low-Risk MDS Patient For Allogeneic Hematopoieti…
Feat.
U. Platzbecker
16:07
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
What is New In MDS in 2018?
Feat.
V. Santini
11:10
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Inherited Predisposition and Pediatric MDS
Feat.
M. Wlodarski
15:59
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Should MDS Diagnosis Still Be Mainly Based on Morphology? Yes
Feat.
R. Hasserjian
20:14
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Should MDS Diagnosis Still Be Mainly Based on Morphology? No
Feat.
L. Godley
15:20
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Improving MDS Results of Hypomethylating Agents (HMAs): Current Situ…
Feat.
P. Fenaux
09:09
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract MDS 161: Distinct Genomic Associations to Predict Acut…
Feat.
Y. Madanat
09:28
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract MDS 304: Mutational Landscape of Therapy-Related Myelo…
Feat.
T. Kuzmanovic
15:35
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Problems Ahead in MDS: What Is Next?
Feat.
G. Garcia-Manero